Výsledky vyhledávání - Yanagitani, Noriko
- Zobrazuji výsledky 1 - 20 z 33
- Přejít na další stránku
-
1
Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer Autor Kaira, Kyoichi, Yanagitani, Noriko, Sunaga, Noriaki, Imai, Hisao, Ono, Akihiro, Koga, Yasuhiko, Hisada, Takeshi, Ishizuka, Tamotsu, Yamada, Masanobu
Vydáno 2017Text -
2
Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report Autor Yanagitani, Noriko, Kaira, Kyoichi, Ishizuka, Tamotsu, Aoki, Haruka, Utsugi, Mitsuyoshi, Shimizu, Yasuo, Sunaga, Noriaki, Endou, Katsuaki, Hisada, Takeshi, Mori, Masatomo
Vydáno 2009Text -
3
Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis Autor Shimizu, Yasuo, Matsuzaki, Shinichi, Dobashi, Kunio, Yanagitani, Noriko, Satoh, Takahiro, Koka, Masashi, Yokoyama, Akihito, Ohkubo, Takeru, Ishii, Yasuyuki, Kamiya, Tomihiro, Mori, Masatomo
Vydáno 2011Text -
4
A phase II study of S-1 in relapsed small cell lung cancer Autor KUDO, KEITA, OHYANAGI, FUMIYOSI, HORIIKE, ATSUSHI, MIYAUCHI, EISAKU, TAHANAKA, HISASHI, YANAGITANI, NORIKO, SAITO, RYOUTA, KABURAKI, KYOUHEI, SAKATANI, TOSHIO, HORAI, TAKESHI, NISHIO, MAKOTO
Vydáno 2013Text -
5
Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab Autor Kawashima, Yosuke, Nishikawa, Shingo, Ninomiya, Hironori, Yoshida, Reiko, Takano, Natsuki, Oguri, Tomoyo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ishikawa, Yuichi, Nishio, Makoto
Vydáno 2019Text -
6
GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer Autor Shimizu, Yuki, Okada, Koutaroh, Adachi, Jun, Abe, Yuichi, Narumi, Ryohei, Uchibori, Ken, Yanagitani, Noriko, Koike, Sumie, Takagi, Satoshi, Nishio, Makoto, Fujita, Naoya, Katayama, Ryohei
Vydáno 2022Text -
7
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer Autor Takahashi, Ken, Seto, Yosuke, Okada, Koutaroh, Uematsu, Shinya, Uchibori, Ken, Tsukahara, Mika, Oh‐hara, Tomoko, Fujita, Naoya, Yanagitani, Noriko, Nishio, Makoto, Okubo, Kenichi, Katayama, Ryohei
Vydáno 2020Text -
8
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (... Autor Tanaka, Hisashi, Sakamoto, Hiroaki, Akita, Takahiro, Ohyanagi, Fumiyoshi, Kawashima, Yosuke, Tambo, Yuichi, Tanimoto, Azusa, Horiike, Atsushi, Miyauchi, Eisaku, Tsuchiya‐Kawano, Yuko, Yanagitani, Noriko, Nishio, Makoto
Vydáno 2022Text -
9
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer Autor KAIRA, KYOICHI, ORIUCHI, NOBORU, IMAI, HISAO, SHIMIZU, KIMIHIRO, YANAGITANI, NORIKO, SUNAGA, NORIAKI, HISADA, TAKESHI, KAWASHIMA, OSAMU, KAMIDE, YOSUKE, ISHIZUKA, TAMOTSU, KANAI, YOSHIKATSU, NAKAJIMA, TAKASHI, MORI, MASATOMO
Vydáno 2010Text -
10
EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer Autor Sonoda, Tomoaki, Nishikawa, Shingo, Sakakibara, Rie, Saiki, Masafumi, Ariyasu, Ryo, Koyama, Junji, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto
Vydáno 2018Text -
11
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms Autor Yanagitani, Noriko, Uchibori, Ken, Koike, Sumie, Tsukahara, Mika, Kitazono, Satoru, Yoshizawa, Takahiro, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Tambo, Yuichi, Nishikawa, Shingo, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto
Vydáno 2020Text -
12
Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2 Autor Uchibori, Ken, Takano, Natsuki, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto
Vydáno 2021Text -
13
Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib Autor Sakamoto, Hiroaki, Yanagitani, Noriko, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Tasaka, Sadatomo, Nishio, Makoto
Vydáno 2021Text -
14
Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor Autor Sakai, Kazuko, Horiike, Atsushi, Irwin, Darryl L., Kudo, Keita, Fujita, Yoshihiko, Tanimoto, Azusa, Sakatani, Toshio, Saito, Ryota, Kaburaki, Kyohei, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto, Nishio, Kazuto
Vydáno 2013Text -
15
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer Autor Gong, Bo, Kiyotani, Kazuma, Sakata, Seiji, Nagano, Seiji, Kumehara, Shun, Baba, Satoko, Besse, Benjamin, Yanagitani, Noriko, Friboulet, Luc, Nishio, Makoto, Takeuchi, Kengo, Kawamoto, Hiroshi, Fujita, Naoya, Katayama, Ryohei
Vydáno 2019Text -
16
Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell... Autor Koyama, Junji, Horiike, Atsushi, Yoshizawa, Takahiro, Dotsu, Yosuke, Ariyasu, Ryo, Saiki, Masafumi, Sonoda, Tomoaki, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto
Vydáno 2019Text -
17
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients Autor Kitazono, Satoru, Sakai, Kazuko, Yanagitani, Noriko, Ariyasu, Ryo, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Uchibori, Ken, Horiike, Atsushi, Nishio, Kazuto, Nishio, Makoto
Vydáno 2019Text -
18
Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer Autor HASEGAWA, TSUKASA, YANAGITANI, NORIKO, NINOMIYA, HIRONORI, SAKAMOTO, HIROAKI, TOZUKA, TAKEHIRO, YOSHIDA, HIROSHI, AMINO, YOSHIAKI, UEMATSU, SHINYA, YOSHIZAWA, TAKAHIRO, ARIYASU, RYO, UCHIBORI, KEN, KITAZONO, SATORU, HORIIKE, ATSUSHI, NISHIO, MAKOTO
Vydáno 2020Text -
19
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice Autor Ariyasu, Ryo, Uchibori, Ken, Ninomiya, Hironori, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Sakamaoto, Hiroaki, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Takeuchi, Kengo, Nishio, Makoto
Vydáno 2020Text -
20
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand... Autor Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Uchibori, Ken, Yanagitani, Noriko, Horiike, Atsushi, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Vydáno 2020Text